International Journal of Clinical Research

Objective To observe the effect of hyperbaric oxygen therapy on cognitive impairment patients with hypertensive intracerebral hemorrhage. Methods This study investigated the effects of timing of hyperbaric oxygen (HBO) treatment on cognitive function and daily living ability in patients with hypertensive intracerebral hemorrhage (HICH) through a randomized controlled trial. 90 patients with HICH were included and divided into a control group (30 cases), group A (30 cases treated with HBO<1 week after surgery), and group B (30 cases treated with HBO>1 week after surgery). Two groups of patients were treated continuously for 3 months, and the overall treatment effect, cognitive function, and changes in daily living abilities were observed. Results Combined with statistics, after one month of treatment, the total effective rate of Group A was 83.3%, Group B was 73.3%, and the control group was 56.7%. After 3 months of treatment, the total effective rate of Group A was 86.7%, Group B was 73.3%, and the control group was 60.0%, P<0.05. There was no significant difference in cognitive function levels among the three groups before treatment. After treatment, patients in group A had higher cognitive function than those in group B, and patients in group B had higher cognitive function than the control group, P<0.05. Changes in daily living abilities showed no significant difference among the three groups before treatment. After treatment, patients in group A had higher cognitive function than those in group B, and patients in group B had higher cognitive function than the control group, P<0.05. Conclusion Hyperbaric oxygen therapy can improve the overall treatment efficiency, cognitive function, and daily living ability of patients with cognitive impairment in hypertensive intracerebral hemorrhage.

Hypertensive intracerebral hemorrhage; Hyperbaric oxygen therapy; Cognitive impairment; Randomized controlled trials; Neurological function score